.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Medtronic
US Army
Moodys
Harvard Business School
Queensland Health
Argus Health
Boehringer Ingelheim
Cipla
Deloitte

Generated: July 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Contrast media comprising a non-ionic contrast agent with low levels of sodium and calcium ions
Abstract:The physiological acceptability of contrast media, especially media for use in angiography, may be enhanced by inclusion of sub-plasma levels of sodium and calcium and, optionally, potassium and/or magnesium, for example 30 mM Na, 0.15 mM Ca, 0.9 mM K and 0.1 mM Mg.
Inventor(s): Almen; Torsten (Malmo, SE), Baath; Lars (Malmo, SE), Jynge; Per (Trondheim, NO), Oksendal; Audun Nesheim (Oslo, NO)
Assignee: Nycomed Imaging AS (Oslo, NO)
Application Number:08/616,245
Patent Claims: 1. A contrast medium composition comprising a physiologically tolerable aqueous carrier medium with dissolved therein: a non-ionic contrast agent; a .[.physiologically tolerable.]. sodium .[.compound.]. .Iadd.salt .Iaddend.providing a sodium ion concentration of 15 to 75 mM Na; a .[.physiologically tolerable.]. calcium salt providing a calcium ion concentration of 0.05 to 0.8 mM Ca.Iadd., the ratio of concentrations of said sodium to said calcium ion provided by said sodium and calcium salts being greater than 60.Iaddend.; and optionally also at least one salt selected from .[.physiologically tolerable.]. potassium and magnesium salts, the total concentration of said .Iadd.potassium salt being up to .Iaddend.2 mM K; wherein .[.the ratio of sodium to calcium ions is greater than 55.]. .Iadd.said salts are selected from the group consisting of chloride, phosphate or hydrogencarbonate salts.Iaddend..

2. A composition as claimed in claim 1 containing .[.calcium.]. .Iadd.said calcium salt .Iaddend.at a concentration of 0.05 to 0.7 mM Ca.sup.2+.

3. A composition as claimed in claim 1 containing .[.calcium.]. .Iadd.said calcium salt .Iaddend.at a concentration of 0.1 to 0.6 mM Ca.sup.2+.

4. A composition as claimed in claim 1 containing .[.potassium.]. .Iadd.said potassium salt .Iaddend.at a concentration of 0.2 to 1.5 mM K.sup.+.

5. A composition as claimed in claim 1 .[.and.]. containing .[.potassium.]. .Iadd.said potassium salt .Iaddend.at a concentration of 0.3 to 1.2 mM K.sup.+.

6. A composition as claimed in claim 1 containing .[.magnesium.]. .Iadd.said magnesium salt .Iaddend.at a concentration of up to 0.8 mM Mg.sup.2+.

7. A composition as claimed in claim 1 containing .[.magnesium.]. .Iadd.said magnesium salt .Iaddend.at a concentration of 0.5 to 0.4 mM Mg.sup.2+.

8. A composition as claimed in claim 1 containing an iodinated X-ray contrast agent.

9. A composition as claimed in claim 8 containing a contrast agent selected from iohexol, ioversol, iopamidol, iotrolan, ioxaglate and iodixanol.

10. A composition as claimed in claim 8 wherein sodium, calcium, potassium and magnesium .Iadd.salts .Iaddend.are present at concentrations of 25-35 mM Na.sup.+, 0.1 to 0.3 mM Ca.sup.2+, 0.3 to 1.2 mM K.sup.+ and 0.05 to 0.2 mM Mg.sup.2+ and wherein, where said contrast agent is of ratio 6 or greater, said medium contains a further physiologically tolerable osmoactive agent.

11. A composition as claimed in claim 8 wherein .Iadd.said .Iaddend.sodium, calcium, potassium and magnesium .Iadd.salts .Iaddend.are present at concentrations of 65-75 mM Na.sup.+, 0.3-0.6 mM Ca.sup.2+, 0.5-2.0 mM K.sup.+ and 0.1-0.4 mM Mg.sup.2+ and wherein said contrast agent is of ratio 6 or greater.

12. A composition as claimed in claim 1 having an osmolality of 290-320 mosm/kg H.sub.2 O.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Dow
Medtronic
Daiichi Sankyo
Accenture
Farmers Insurance
AstraZeneca
US Army
Merck
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot